WILLIAM JL RIEFLIN
CIK 1182471 · Executive Chairman · last filed 2025-05-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
5
Total Filings
53
Lifetime Open-Market Net
$275.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LYEL | Director | — | $13.50 | — | $0 | 5 | 2025-05-19 |
| RAPT Therapeutics, Inc. (RAPT) Delisted | Director | 94,722 | $58.01 | $5.49M | $258.2K | 11 | 2024-05-23 |
| NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Executive Chairman | 0 | $1.54 | $0 | $0 | 6 | 2024-04-08 |
| XENOPORT INC (XNPT) Delisted | Director | 0 | — | — | $17.0K | 24 | 2016-07-06 |
| Anacor Pharmaceuticals, Inc. (ANAC) Delisted | Director | 0 | $10.19 | $0 | $0 | 7 | 2016-06-24 |
Recent Filings · Page 2 of 6
53 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-10 | LYEL | Grant (A) | — | $0 | EDGAR |
| 2022-05-26 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-04-04 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-04 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-24 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-18 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-11-20 | RAPT Therapeutics, Inc. (RAPT) Delisted | Buy (P) | +10,000 | $162.2K | EDGAR |
| 2020-06-19 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-06 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-11-04 | RAPT Therapeutics, Inc. (RAPT) Delisted | Mixed | +68,056 | $96.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.